These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8138903)

  • 61. Development of Multiple-Unit Floating Drug Delivery System of Clarithromycin: Formulation, in vitro Dissolution by Modified Dissolution Apparatus, in vivo Radiographic Studies in Human Volunteers.
    Reddy AB; Reddy ND
    Drug Res (Stuttg); 2017 Jul; 67(7):412-418. PubMed ID: 28449156
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Gastroretentive dosage forms: overview and special case of Helicobacter pylori.
    Bardonnet PL; Faivre V; Pugh WJ; Piffaretti JC; Falson F
    J Control Release; 2006 Mar; 111(1-2):1-18. PubMed ID: 16403588
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of a cellulose-containing weight-loss supplement on gastric emptying and sensory functions.
    Berthold HK; Unverdorben S; Degenhardt R; Unverdorben M; Gouni-Berthold I
    Obesity (Silver Spring); 2008 Oct; 16(10):2272-80. PubMed ID: 18719632
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of Coadministered Water on the In Vivo Performance of Oral Formulations Containing N-Acetylcysteine: An In Vitro Approach Using the Dynamic Open Flow-Through Test Apparatus.
    Sager M; Schneider F; Jedamzik P; Wiedmann M; Schremmer E; Koziolek M; Weitschies W
    Mol Pharm; 2017 Dec; 14(12):4272-4280. PubMed ID: 29064257
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Empirical study in the relation of gastric mucosal lesion with gastric emptying and gastric acid secretion].
    Zhang HF; Xue YW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):472-6. PubMed ID: 18803054
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The In vitro/vivo Evaluation of Prepared Gastric Floating Tablets of Berberine Hydrochloride.
    Ji J; He X; Yang XL; Du WJ; Cui CL; Wang L; Wang X; Zhang CF; Guo CR
    AAPS PharmSciTech; 2017 Aug; 18(6):2149-2156. PubMed ID: 28035611
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A new approach in gastroretentive drug delivery system using cholestyramine.
    Umamaheshwari RB; Jain S; Jain NK
    Drug Deliv; 2003; 10(3):151-60. PubMed ID: 12944135
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Development and Evaluation of Compression Coating Gastro-Floating Tablet of Alfuzosin Hydrochloride for Zero-Order Controlled Release.
    Gong L; Sun Y; Yu M; Gao Y; Zou M; Cheng G
    AAPS PharmSciTech; 2018 Oct; 19(7):3277-3286. PubMed ID: 30215168
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Preparation and in vitro characterization of a non-effervescent floating drug delivery system for poorly soluble drug, glipizide.
    Meka VS; Pillai S; Dharmalingham SR; Sheshala R; Gorajana A
    Acta Pol Pharm; 2015; 72(1):193-204. PubMed ID: 25850215
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Formulation and optimization of gastric floating drug delivery system using Central composite design and its biopharmaceutical evaluation.
    Meka VS; Thing LK; Gorajana A; Kolapalli VR
    Pak J Pharm Sci; 2015 Jul; 28(4):1373-87. PubMed ID: 26142528
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The effect of formulation on oesophageal transit.
    Channer KS; Virjee JP
    J Pharm Pharmacol; 1985 Feb; 37(2):126-9. PubMed ID: 2858546
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Simulating the postprandial stomach: physiological considerations for dissolution and release testing.
    Koziolek M; Garbacz G; Neumann M; Weitschies W
    Mol Pharm; 2013 May; 10(5):1610-22. PubMed ID: 23506381
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Design and in vitro evaluation of effervescent gastric floating drug delivery systems of propanolol HCl.
    Meka VS; Songa AS; Nali SR; Battu JR; Kolapalli VR
    Invest Clin; 2012 Mar; 53(1):60-70. PubMed ID: 22524109
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The use of citric acid to prolong the in vivo gastro-retention of a floating dosage form in the fasted state.
    Stops F; Fell JT; Collett JH; Martini LG; Sharma HL; Smith AM
    Int J Pharm; 2006 Feb; 308(1-2):8-13. PubMed ID: 16338108
    [TBL] [Abstract][Full Text] [Related]  

  • 75. In vitro and in vivo studies of sustained-release floating dosage forms containing salbutamol sulfate.
    Babu VB; Khar RK
    Pharmazie; 1990 Apr; 45(4):268-70. PubMed ID: 2381979
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Analysis of small intestinal transit and colon arrival times of non-disintegrating tablets administered in the fasted state.
    Pišlar M; Brelih H; Mrhar A; Bogataj M
    Eur J Pharm Sci; 2015 Jul; 75():131-41. PubMed ID: 25769525
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Features and Facts of a Gastroretentive Drug Delivery System-A Review.
    Vinchurkar K; Sainy J; Khan MA; Mane S; Mishra DK; Dixit P
    Turk J Pharm Sci; 2022 Aug; 19(4):476-487. PubMed ID: 36047602
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Impact of gastric and bowel surgery on gastrointestinal drug delivery.
    Hua S; Lye EC
    Drug Deliv Transl Res; 2023 Jan; 13(1):37-53. PubMed ID: 35585472
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Advances in Oral Drug Delivery for Regional Targeting in the Gastrointestinal Tract - Influence of Physiological, Pathophysiological and Pharmaceutical Factors.
    Hua S
    Front Pharmacol; 2020; 11():524. PubMed ID: 32425781
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Development and characterization of novel site specific hollow floating microspheres bearing 5-Fu for stomach targeting.
    Bhardwaj P; Chaurasia D; Singh R; Swarup A
    ScientificWorldJournal; 2014; 2014():705259. PubMed ID: 25383377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.